GST levied on date-expired and damaged stocks costs about â‚¹500 crore per annum to the Indian pharmaceutical industry, said DG Shah, Secretary General of the Indian Pharmaceutical Alliance. He said, "GST should be exempted on date-expired and damaged stocks, which are returned by the retail chemist to the pharmaceutical companies." 